SKIN The Journal of Cutaneous Medicine

SKIN The Journal of Cutaneous Medicine Vol. 2 (2018): Supplemental Issue: Scientific Posters Presented at 2018 Winter Clinical Dermatology Conference®-Hawaii - Melanoma
Efficacy Outcomes in the Phase 3 COMBI-AD Study of Adjuvant Dabrafenib Plus Trametinib vs Placebo in Patients with Stage III BRAFV600E/K-Mutant Melanoma
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 5 No. 1 (2021): January Issue & Poster Presentations (WC21 Dermatology Conference®) - Poster Presentations from WC21 Clinical Dermatology Conference®: Skin Cancer
Restricted Mean Survival Time and Cure-Rate Modeling in Estimating Relapse-Free Survival Benefit With Adjuvant Dabrafenib + Trametinib Treatment in Melanoma
Abstract Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas - Skin Cancer
Association Between Baseline Disease Characteristics and Relapse-Free Survival in Patients With BRAF V600–Mutant Resected Stage III Melanoma Treated With Adjuvant Dabrafenib + Trametinib or Placebo
Abstract Poster PDF